PT Jayamas Medica Industri Tbk (IDX:OMED)
157.00
-4.00 (-2.48%)
Mar 27, 2025, 4:02 PM WIB
IDX:OMED Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Revenue | 1,885,822 | 1,736,990 | 1,739,054 | 2,226,573 | 1,994,540 | Upgrade
|
Revenue Growth (YoY) | 8.57% | -0.12% | -21.89% | 11.63% | 62.41% | Upgrade
|
Cost of Revenue | 1,261,846 | 1,185,056 | 1,176,045 | 1,322,544 | 957,599 | Upgrade
|
Gross Profit | 623,976 | 551,934 | 563,010 | 904,030 | 1,036,940 | Upgrade
|
Selling, General & Admin | 275,502 | 250,002 | 198,309 | 168,243 | 186,715 | Upgrade
|
Other Operating Expenses | -8,774 | 1,057 | -7,542 | 2,951 | 736.38 | Upgrade
|
Operating Expenses | 266,729 | 251,059 | 190,767 | 171,194 | 187,451 | Upgrade
|
Operating Income | 357,247 | 300,875 | 372,243 | 732,836 | 849,489 | Upgrade
|
Interest Expense | -20,229 | -19,581 | -20,805 | -21,840 | -9,008 | Upgrade
|
Interest & Investment Income | - | 43,520 | 14,371 | 16,909 | 14,945 | Upgrade
|
Currency Exchange Gain (Loss) | - | 1,654 | 6,704 | 1,445 | 5,821 | Upgrade
|
Other Non Operating Income (Expenses) | 57,008 | -341.03 | -403.98 | -328.64 | -149.77 | Upgrade
|
EBT Excluding Unusual Items | 394,026 | 326,127 | 372,109 | 729,020 | 861,098 | Upgrade
|
Gain (Loss) on Sale of Assets | - | 35.59 | 0.04 | 179.92 | 583.7 | Upgrade
|
Pretax Income | 394,026 | 326,162 | 372,109 | 729,200 | 861,681 | Upgrade
|
Income Tax Expense | 70,074 | 65,180 | 81,602 | 158,821 | 168,812 | Upgrade
|
Earnings From Continuing Operations | 323,952 | 260,982 | 290,507 | 570,379 | 692,869 | Upgrade
|
Minority Interest in Earnings | -2,279 | -1,622 | -4,725 | -7,687 | -7,359 | Upgrade
|
Net Income | 321,673 | 259,360 | 285,782 | 562,692 | 685,510 | Upgrade
|
Net Income to Common | 321,673 | 259,360 | 285,782 | 562,692 | 685,510 | Upgrade
|
Net Income Growth | 24.03% | -9.25% | -49.21% | -17.92% | 203.04% | Upgrade
|
Shares Outstanding (Basic) | - | 27,059 | 27,059 | 27,059 | 27,455 | Upgrade
|
Shares Outstanding (Diluted) | - | 27,059 | 27,059 | 27,059 | 27,455 | Upgrade
|
Shares Change (YoY) | - | - | - | -1.44% | -46.28% | Upgrade
|
EPS (Basic) | - | 9.59 | 10.56 | 20.80 | 24.97 | Upgrade
|
EPS (Diluted) | - | 9.59 | 10.56 | 20.80 | 24.97 | Upgrade
|
EPS Growth | - | -9.25% | -49.21% | -16.71% | 464.16% | Upgrade
|
Free Cash Flow | 249,245 | -22,031 | 17,549 | 422,386 | 228,771 | Upgrade
|
Free Cash Flow Per Share | - | -0.81 | 0.65 | 15.61 | 8.33 | Upgrade
|
Dividend Per Share | - | 6.050 | - | 10.870 | 17.000 | Upgrade
|
Dividend Growth | - | - | - | -36.06% | - | Upgrade
|
Gross Margin | 33.09% | 31.77% | 32.37% | 40.60% | 51.99% | Upgrade
|
Operating Margin | 18.94% | 17.32% | 21.40% | 32.91% | 42.59% | Upgrade
|
Profit Margin | 17.06% | 14.93% | 16.43% | 25.27% | 34.37% | Upgrade
|
Free Cash Flow Margin | 13.22% | -1.27% | 1.01% | 18.97% | 11.47% | Upgrade
|
EBITDA | 398,725 | 335,378 | 392,559 | 752,142 | 864,958 | Upgrade
|
EBITDA Margin | 21.14% | 19.31% | 22.57% | 33.78% | 43.37% | Upgrade
|
D&A For EBITDA | 41,478 | 34,504 | 20,317 | 19,307 | 15,469 | Upgrade
|
EBIT | 357,247 | 300,875 | 372,243 | 732,836 | 849,489 | Upgrade
|
EBIT Margin | 18.94% | 17.32% | 21.40% | 32.91% | 42.59% | Upgrade
|
Effective Tax Rate | 17.78% | 19.98% | 21.93% | 21.78% | 19.59% | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.